Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy

Key Clinical Message In our case, the use of a low intravenous bolus dose of rFVIIa (recombinant factor VII activated; 15‐20 mcg/kg) was effective and uneventful in controlling late postprocedural PDT bleeding associated with thrombocytopenia that cannot be corrected and after all other treatments f...

Descripción completa

Detalles Bibliográficos

Autores principales:	Dario Nicosia, Antonino Federico, Ivan Vigna, Pasquale Iozzo, Giovanni Misseri, Andrea Cortegiani
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wiley 2019-04-01
Colección:	Clinical Case Reports
Materias:	activated factor VII percutaneous tracheostomy postoperatory bleeding rFVIIa Thrombocytopenia
Acceso en línea:	https://doi.org/10.1002/ccr3.2061
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!